IRIS
SCORSETTI, Marta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.817
AS - Asia 11.135
EU - Europa 3.565
SA - Sud America 2.340
AF - Africa 574
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 19
AN - Antartide 1
Totale 35.495
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.526
SG - Singapore 7.135
BR - Brasile 1.919
CN - Cina 1.574
VN - Vietnam 1.177
FI - Finlandia 647
DE - Germania 608
IE - Irlanda 540
IT - Italia 404
NG - Nigeria 363
FR - Francia 309
HK - Hong Kong 297
GB - Regno Unito 236
IN - India 187
NL - Olanda 184
SE - Svezia 157
AR - Argentina 151
CA - Canada 149
RU - Federazione Russa 115
BD - Bangladesh 102
TR - Turchia 90
IQ - Iraq 85
MX - Messico 75
EC - Ecuador 67
ID - Indonesia 66
ZA - Sudafrica 59
CO - Colombia 55
PK - Pakistan 53
CL - Cile 52
IL - Israele 51
UA - Ucraina 50
PL - Polonia 48
ES - Italia 41
AU - Australia 38
BE - Belgio 38
SA - Arabia Saudita 36
VE - Venezuela 35
AT - Austria 32
JP - Giappone 32
UZ - Uzbekistan 30
MA - Marocco 29
CZ - Repubblica Ceca 25
JO - Giordania 25
KE - Kenya 24
DZ - Algeria 22
EG - Egitto 22
PY - Paraguay 21
KZ - Kazakistan 19
PE - Perù 19
NP - Nepal 18
OM - Oman 18
RO - Romania 18
AZ - Azerbaigian 17
LT - Lituania 17
PH - Filippine 17
TN - Tunisia 17
AE - Emirati Arabi Uniti 16
UY - Uruguay 15
A2 - ???statistics.table.value.countryCode.A2??? 13
MY - Malesia 13
CH - Svizzera 11
GR - Grecia 11
JM - Giamaica 10
HN - Honduras 9
NO - Norvegia 9
PA - Panama 9
AL - Albania 8
DO - Repubblica Dominicana 8
LB - Libano 8
BG - Bulgaria 7
IR - Iran 7
PS - Palestinian Territory 7
PT - Portogallo 7
SN - Senegal 7
CI - Costa d'Avorio 6
CR - Costa Rica 6
GE - Georgia 6
HU - Ungheria 6
AM - Armenia 5
BA - Bosnia-Erzegovina 5
BH - Bahrain 5
BO - Bolivia 5
BY - Bielorussia 5
DK - Danimarca 5
ET - Etiopia 5
HR - Croazia 5
KG - Kirghizistan 5
KW - Kuwait 5
EU - Europa 4
GA - Gabon 4
GT - Guatemala 4
KR - Corea 4
NZ - Nuova Zelanda 4
SI - Slovenia 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
AO - Angola 3
BB - Barbados 3
EE - Estonia 3
Totale 35.435
Salva come PNG Salva come JPEG
Città #
Singapore 3.258
Wilmington 2.603
Chandler 2.172
Dallas 1.806
The Dalles 1.034
San Mateo 1.014
Ashburn 951
Shanghai 763
Ann Arbor 720
Helsinki 644
San Jose 578
Dublin 535
Leawood 456
Lawrence 438
Princeton 438
Boardman 404
Ho Chi Minh City 383
Benin City 361
Beijing 341
Hanoi 296
New York 285
Fairfield 261
Hong Kong 257
Woodbridge 251
Paris 240
Falkenstein 239
São Paulo 181
Amsterdam 152
Milan 119
London 107
Los Angeles 103
Santa Clara 101
Seattle 96
Toronto 75
Norwalk 72
Rio de Janeiro 62
Orem 57
Da Nang 56
San Diego 52
Belo Horizonte 49
Kocaeli 46
Phoenix 46
Haiphong 45
Council Bluffs 42
Brussels 36
Chennai 36
Baghdad 35
Warsaw 34
Porto Alegre 32
Curitiba 31
Tokyo 30
Brasília 29
Naples 29
Dhaka 28
Montreal 28
Hillsboro 27
Munich 27
Frankfurt am Main 26
Mexico City 26
Tashkent 25
Guarulhos 24
Johannesburg 24
Nuremberg 24
Amman 23
Guayaquil 23
Hải Dương 23
Pune 23
Redwood City 23
Brooklyn 21
Buffalo 21
Campinas 21
Fortaleza 21
Thái Bình 21
Des Moines 20
Nairobi 20
Salvador 20
Santiago 20
Biên Hòa 19
Manchester 19
Monmouth Junction 19
Can Tho 18
Quito 18
Redmond 18
San Francisco 18
Vienna 18
Lahore 17
Moscow 17
Ninh Bình 17
Santo André 17
Columbus 16
Denver 16
Stockholm 16
Boston 15
Osasco 15
Recife 15
Brno 14
Erbil 14
Ribeirão Preto 14
Atlanta 13
Baku 13
Totale 23.416
Salva come PNG Salva come JPEG
Nome #
11C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer. 745
11C Choline PET Guided Salvage Radiotherapy with Volumetric Modulation Arc Therapy and Hypofractionation for Recurrent Prostate Cancer after HIFU Failure: Preliminary Results of Tolerability and Acute Toxicity 675
Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases 136
"Early Clinical Assessment Of Feasibility And Safety In Flattering Filter Free (FFF) Based Stereotactic Body Radiotherapy (SBRT) Treatments" 133
Can advanced new radiation therapy technologies improve outcome of high grade glioma (HGG) patients? Analysis of 3D-conformal radiotherapy (3DCRT) versus volumetric-modulated arc therapy (VMAT) in patients treated with surgery, concomitant and adjuvant chemo-radiotherapy 128
A circulating miRNA signature to implement diagnostic imaging analysis in young early-stage breast cancer patients 125
Carbon-11-methionine PET-CT as an imaging biomarker in brain gliomas eligible for surgery 124
Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study 120
Administration of temozolomide during and after radiotherapy for newly diagnosed high-grade gliomas excluding glioblastoma multiforme 119
"Reirradiation: hopes and concerns of the radiation oncologist" Reply 116
Assessment of prognostic factors in patients with metastatic epidural spinal cord compression (MESCC) from solid tumor after surgery plus radiotherapy: a single institution experience 116
High incidence of hypocalcemia and serum creatinine increase in patients with bone metastases treated with zoledronic acid 115
A broad scope knowledge based model for optimization of VMAT in esophageal cancer: validation and assessment of plan quality among different treatment centers. 111
Accuracy evaluation of fusion of CT, MR, and SPECT images using commercially available software packages (SRS PLATO and IFS) 111
ChemoRadiotherapy for Oesophageal cancer followed by Surgery Study (CROSS): Single Center Experience 111
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 111
A Radiomic Approach to Predict Nodal and Distant Relapse in Patients Treated with Stereotactic Body Radiation Therapy for Early Stage NSCLC 111
Can HSRS on tumor bed replace WBRT in resected brain metastases? Results of a phase II study 110
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) 110
Can SBRT improve the prognosis of unresectable pancreatic cancer? Clinical results on 106 patients 110
Role of Surgical Resection in Patients with Single Large Brain Metastases: Feasibility, Morbidity, and Local Control Evaluation. 109
A LARGE, MULTICENTER, RETROSPECTIVE STUDY ON EFFICACY AND SAFETY OF STEREOTACTIC BODY RADIOTHERAPY (SBRT) IN OLIGOMETASTATIC OVARIAN CANCER (MITO RT1 STUDY) 109
Outcome appraisal of patients with limited brain metastases (BMs) from non small cell lung cancer (NSCLC) treated with different local therapeutic strategies: a single institute evaluation. 108
A radiomic approach to predicting nodal relapse and disease-specific survival in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer. 108
Adjuvant chemotherapy and hypofractionated VMAT treatment with SIB for early stage breast cancer: A prospective evaluation of acute toxicity and cosmetic results 103
SALVAGE RADIOTHERAPY WITH VOLUMETRIC MODULATION ARC THERAPY AND HYPOFRACTIONATION FOR RECURRENT PROSTATE CANCER AFTER HIFU FAILURE 103
Survival outcome and prognostic factors after pulmonary metastasectomy in sarcoma patients 102
Addition of temozolomide to radiotherapy for treatment of newly diagnosed anaplastic gliomas 101
Adjuvant volumetric modulated arc therapy compared to 3D conformal radiation therapy for newly diagnosed soft tissue sarcoma of the extremities: outcome and toxicity evaluation 100
Checkpoint inhibitors as treatment for malignant gliomas: "A long way to the top" 100
Accuracy evaluation of the optical surface monitoring system on EDGE linear accelerator in a phantom study. 100
Hypofractionated radiation therapy (HFRT) versus conventional fractionated radiation therapy (CRT) for newly diagnosed glioblastoma patients. A propensity score matched analysis. 99
Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study 99
Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma 98
Hypofractionation with simultaneous boost in breast cancer patients receiving adjuvant chemotherapy: A prospective evaluation of a case series and review of the literature 98
Adjuvant radiotherapy in endometrial cancer: Volumetric Modulated Intensity Arc Therapy vs 3DRT 98
A Multi-Institutional Analysis on the Use of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Lymph Node Oligometastases in Prostate Cancer Patients 97
Cranio-spinal irradiation with volumetric modulated arc therapy: A multi-institutional treatment experience 96
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 95
Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach 94
Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction 93
Diagnostic accuracy of C-11-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma 93
A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group 92
Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography 92
Applying failure mode effects and criticality analysis in radiotherapy: Lessons learned and perspectives of enhancement 90
Role of C-11-choline PET/CT in radiation therapy planning of patients with prostate cancer 89
Hypofractionated stereotactic radiation therapy in skull base meningiomas 88
Developing an adolescent and young adult (AYA) cancer program in an Italian adult high-volume cancer center. 88
DCIS treated with breast conservative surgery and radiotherapy: a national multicentre experience 88
Liver metastases from colorectal cancer: propensity score-based comparison of stereotactic body radiation therapy vs. microwave ablation 87
Phase II trial of stereotactic body radiation therapy for abdomino-pelvic lymph node oligometastases 87
Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma. 86
The use of radiation therapy for oligoprogressive/oligopersistent oncogene driven non small cell lung cancer: state of the art 86
Acute Toxicity and Quality of Life in a Post-Prostatectomy Ablative Radiation Therapy (POPART) Multicentric Trial 85
Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma 85
Adjuvant radiotherapy for malignant pleural mesothelioma: Challenges and pitfalls 84
Could single-high-dose radiotherapy be considered the new frontier of stereotactic ablative radiation therapy? 84
Hypofractionation in current clinical practice: a flash forward to the near future of radiation oncology? 84
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation 84
Recurrence pattern of stereotactic body radiotherapy in oligometastatic prostate cancer: a multi-institutional analysis. 83
Can thoracic nodes oligometastases be safely treated with image guided hypofractionated radiation therapy? 83
Percutaneous Vertebral Augmentation in Metastatic Disease: State of the Art 83
Early clinical experience with volumetric modulated arc therapy in head and neck cancer patients 82
CRITICAL APPRAISAL OF VOLUMETRIC MODULATED ARC THERAPY IN STEREOTACTIC BODY RADIATION THERAPY FOR METASTASES TO ABDOMINAL LYMPH NODES 82
Liver Metastases-directed Therapy in the Management of Oligometastatic Breast Cancer 82
SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience. 82
Organs at risk in lung SBRT 81
Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade glioma 81
Bronchoscopically-guided conformal radiation therapy for radiographically occult lung carcinoma 81
Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments. 81
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study. 81
STEREOTACTIC BODY RADIATION THERAPY AS LOCAL TREATMENT FOR OLIGOMETASTASES FROM PROSTATE CANCER: EFFICACY AND IMPACT ON SYSTEMIC TREATMENT 81
Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study. 80
Final results of a phase II trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer 80
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 79
Plan robustness in field junction region from arcs with different patient orientation in total marrow irradiation with VMAT. 79
Intracranial Meningiomas: A Systematic Analysis of Prognostic Factors for Recurrence in a Large Single Institution Surgical Series 79
Adjuvant chemotherapy and hypofractionated VMAT treatment with SIB for early stage breast cancer 79
The 70-year-old newly diagnosed glioblastoma patients are older than the 65-year-old? Outcome evaluation of the two categories in a matched case control study with propensity score balancing 79
Discrepancies between UICC and AJCC TNM classifications for oral cavity tumors in the 8th editions and following versions 78
Critical Appraisal of the Risk of Secondary Cancer Induction From Breast Radiation Therapy With Volumetric Modulated Arc Therapy Relative to 3D Conformal Therapy. 78
SBRT for unresectable locally advanced pancreatic cancer: clinical outcomes on 100 patients 78
High-grade gliomas (HGGs) and immunotherapeutic early-phase clinical trials (ieCTs): A single-center experience 78
Applying Lean-Six-Sigma Methodology in radiotherapy: Lessons learned by the breast daily repositioning case 78
HIGH-GRADE GLIOMAS AND IMMUNOTHERAPEUTIC EARLY PHASE CLINICAL TRIALS: A SINGLE-CENTER EXPERIENCE 78
Comparison of low dose total marrow/total lymphoid irradiation (TMI/TLI) and TBI in haploidentical transplant platform: a retrospective analysis 77
Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience 77
Dosimetric evaluation of different radiotherapy modalities and calculations for soft tissue sarcoma 77
VOLUMETRIC MODULATION ARC RADIOTHERAPY COMPARED WITH STATIC GANTRY INTENSITY-MODULATED RADIOTHERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA TUMOR: A FEASIBILITY STUDY 77
Mesenchymal Tumor Management: Integrating Surgical and Non-Surgical Strategies in Different Clinical Scenarios 76
Feasibility of stereotactic body radiation therapy with volumetric modulated arc therapy and high intensity photon beams for hepatocellular carcinoma patients. 76
Salvage therapy of intraprostatic failure after radical external-beam radiotherapy for prostate cancer: A review 76
Hypofractionated Stereotactic Radiation Therapy in Recurrent High-Grade Glioma: A New Challenge. 76
Value of Surgical Resection in Patients with Newly Diagnosed Grade III Glioma Treated in a Multimodal Approach: Surgery, Chemotherapy and Radiotherapy 76
Temozolomide combined with radiotherapy in the treatment of recurrent cranial meningioma previously treated with multiple surgical resections and two sessions of radiosurgery: a case report and literature review. 76
Assessing the role of Stereotactic Body Radiation Therapy in a large cohort of patients with lymph node oligometastases: Does it affect systemic treatment's intensification? 76
Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1-2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial 75
Moderate hypofractionation and simultaneous integrated boost with volumetric modulated arc therapy (RapidArc) for prostate cancer Report of feasibility and acute toxicity 75
Minimally Invasive Stereotactical Radio-ablation of Adrenal Metastases as an Alternative to Surgery. 75
Stereotactic body radiation therapy for abdominal targets using volumetric intensity modulated arc therapy with RapidArc: Feasibility and clinical preliminary results 75
Totale 10.445
Salva come PNG Salva come JPEG
Categoria #
all - tutte 235.262
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 235.262
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.029 0 0 0 0 0 0 0 0 0 521 15 493
2021/20222.197 98 21 31 545 13 10 87 367 195 236 513 81
2022/20236.230 950 184 550 711 552 514 9 520 1.176 533 461 70
2023/20243.204 206 383 736 116 94 318 131 140 134 60 357 529
2024/20255.284 107 154 91 67 78 576 337 583 786 1.304 573 628
2025/202614.174 2.082 965 1.810 1.704 420 592 3.927 1.115 849 710 0 0
Totale 35.843